BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16888897)

  • 1. New insights into the biology of acute myeloid leukemia and their impact on treatment.
    Hiddemann W; Haferlach T; Schoch C; Behre G; Kohlmann A; Kern W; Feuring-Buske M; Bohlander S
    Verh Dtsch Ges Pathol; 2003; 87():72-8. PubMed ID: 16888897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
    Larson RA; Le Beau MM
    Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
    Larson RA
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival.
    Arber DA; Stein AS; Carter NH; Ikle D; Forman SJ; Slovak ML
    Am J Clin Pathol; 2003 May; 119(5):672-80. PubMed ID: 12760285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.
    Schoch C; Kern W; Schnittger S; Büchner T; Hiddemann W; Haferlach T
    Haematologica; 2004 Sep; 89(9):1082-90. PubMed ID: 15377469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes.
    Lindvall C; Furge K; Björkholm M; Guo X; Haab B; Blennow E; Nordenskjöld M; Teh BT
    Haematologica; 2004 Sep; 89(9):1072-81. PubMed ID: 15377468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of cytogenetic findings in adults with acute myeloid leukemia.
    Mrózek K; Heinonen K; Bloomfield CD
    Int J Hematol; 2000 Oct; 72(3):261-71. PubMed ID: 11185980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
    Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
    Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a pathogenesis-oriented therapy of acute myeloid leukemia.
    Hiddemann W; Spiekermann K; Buske C; Feuring-Buske M; Braess J; Haferlach T; Schoch C; Kern W; Schnittger S; Berdel W; Wörmann B; Heinecke A; Sauerland C; Büchner T;
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):235-45. PubMed ID: 16207531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of specific cytogenetic aberrations with mdr1 gene expression in adult myeloid leukemia and its implication in treatment outcome.
    Schaich M; Harbich-Brutscher E; Pascheberg U; Mohr B; Soucek S; Ehninger G; Illmer T
    Haematologica; 2002 May; 87(5):455-64. PubMed ID: 12010657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new prognostic score for patients with acute myeloid leukemia based on cytogenetics and early blast clearance in trials of the German AML Cooperative Group.
    Haferlach T; Kern W; Schoch C; Schnittger S; Sauerland MC; Heinecke A; Büchner T; Hiddemann W;
    Haematologica; 2004 Apr; 89(4):408-18. PubMed ID: 15075074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific chromosomal aberrations in de novo acute myeloid leukemia: a comparative analysis of results with a report of three novel chromosomal rearrangements t(7;14)(q35;q13), t(8;18)(p11.2;q12), t(13;15) in Indian population.
    Ahmad F; Dalvi R; Das BR; Mandava S
    Cancer Detect Prev; 2008; 32(2):168-77. PubMed ID: 18639991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
    Klaus M; Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
    Cancer Genet Cytogenet; 2004 Nov; 155(1):47-56. PubMed ID: 15527902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary chromosomal abnormalities in acute leukemias.
    Johansson B; Mertens F; Mitelman F
    Leukemia; 1994 Jun; 8(6):953-62. PubMed ID: 8207990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical importance of cytogenetics in acute myeloid leukaemia.
    Mrózek K; Heinonen K; Bloomfield CD
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):19-47. PubMed ID: 11355922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome aberrations in de novo acute myeloid leukemia patients in Kuwait.
    Al Bahar S; Pandita R; Bavishi K; Kreze O; Nath S
    Neoplasma; 2004; 51(3):223-7. PubMed ID: 15254677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic, morphological, and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia.
    Udayakumar AM; Pathare AV; Al-Kindi S; Khan H; Rehmen JU; Zia F; Al-Ghazaly A; Nusrut N; Khan MI; Wali YA; Al-Lamki Z; Dennison D; Raeburn JA
    Cancer Genet Cytogenet; 2007 Sep; 177(2):89-94. PubMed ID: 17854660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of cytogenetics in acute myeloid leukemia.
    Mrózek K; Heinonen K; de la Chapelle A; Bloomfield CD
    Semin Oncol; 1997 Feb; 24(1):17-31. PubMed ID: 9045301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex karyotypes confer a poor survival in adult acute myeloid leukemia with unfavorable cytogenetic abnormalities.
    Chen CC; Yang CF; Lee KD; You JY; Yu YB; Ho CH; Tzeng CH; Chau WK; Hsu HC; Gau JP
    Cancer Genet Cytogenet; 2007 Apr; 174(2):138-46. PubMed ID: 17452256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.